
Bonel Tablet 150 mg (Risedronate Sodium Hydrate)
158.9mg
Tablet · Prescription medication
MyungMoon Pharmaceutical Co., Ltd.
Risedronate sodium hydrate is a bone resorption inhibitor used in the treatment of osteoporosis.
MFDS ingredient code M280458
Risedronate sodium hydrate belongs to the bisphosphonate class of compounds and is used in the treatment of skeletal disorders such as osteoporosis. Its purpose is to inhibit bone destruction, increase bone density, and reduce the risk of fractures.
This compound reduces bone loss by inhibiting the activity of osteoclasts, the cells that break down bone. As a result, bones become stronger and the risk of fractures decreases.
Approved uses differ by product. Check each product's information for its actual use.
Risedronate sodium hydrate has fewer gastrointestinal side effects compared to other bisphosphonates and features improved dosing convenience. Additionally, its bone resorption inhibition effect is strong, making it widely used in the treatment of osteoporosis.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.